3 results
Approved WMOCompleted
Primary objectivesPhase I:To determine the recommended phase 2 dose (RP2D) of the dacomitinib-PD-0325901 combination in patients with KRASm NSCLC Phase II:To determine the progression free survival of the dacomitinib/PD-0325901 combination compared…
Approved WMORecruiting
See section 3.2 on protocol page 24The purpose of the clinical study is to demonstrate the safety and efficacy of the EV ICD System: a complete single-chamber extravascular ICD system with the lead implanted substernally
Approved WMOCompleted
To evaluate the effect of Obeticholic Acid on clinical outcomes in subjects with primary biliary cholangitis